Quince Therapeutics, Inc.
QNCX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,442 | -$16,049 | -$15,030 | -$12,458 |
| Dep. & Amort. | $36 | $35 | $32 | $16 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,273 | $1,386 | $1,125 |
| Change in WC | $194 | -$1,872 | $2,051 | $1,895 |
| Other Non-Cash | $3,284 | $5,198 | $1,960 | $1,870 |
| Operating Cash Flow | -$9,928 | -$11,415 | -$9,601 | -$7,552 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$74 | -$126 | -$148 | -$133 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$15,707 | -$11,835 | -$1,954 | $0 |
| Inv. Sales/Matur. | $14,000 | $18,000 | $12,645 | $10,510 |
| Other Inv. Act. | $0 | $0 | $355 | $490 |
| Investing Cash Flow | -$1,781 | $6,039 | $10,898 | $10,867 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,376 | $0 | $87 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $14,412 | $0 | $0 |
| Financing Cash Flow | $1,376 | $14,412 | $87 | $0 |
| Forex Effect | -$41 | $19 | $175 | $222 |
| Net Chg. in Cash | -$10,374 | $9,055 | $1,559 | $3,537 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16,826 | $7,771 | $6,212 | $2,675 |
| End Cash | $6,452 | $16,826 | $7,771 | $6,212 |
| Free Cash Flow | -$10,002 | -$11,541 | -$9,749 | -$7,685 |